267 related articles for article (PubMed ID: 31158574)
1. Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.
Roquero I; Cantizani J; Cotillo I; Manzano MP; Kessler A; Martín JJ; McNamara CW
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():58-68. PubMed ID: 31158574
[TBL] [Abstract][Full Text] [Related]
2. Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
Don R; Ioset JR
Parasitology; 2014 Jan; 141(1):140-6. PubMed ID: 23985066
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
4. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
[TBL] [Abstract][Full Text] [Related]
5. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
[TBL] [Abstract][Full Text] [Related]
6. High throughput screening for anti-Trypanosoma cruzi drug discovery.
Alonso-Padilla J; Rodríguez A
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3259. PubMed ID: 25474364
[TBL] [Abstract][Full Text] [Related]
7. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
[TBL] [Abstract][Full Text] [Related]
8. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
10.
Tadele M; Abay SM; Makonnen E; Hailu A
Drug Des Devel Ther; 2020; 14():1307-1317. PubMed ID: 32280200
[TBL] [Abstract][Full Text] [Related]
11. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058
[TBL] [Abstract][Full Text] [Related]
12. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
[TBL] [Abstract][Full Text] [Related]
14. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi.
Oh S; Kim S; Kong S; Yang G; Lee N; Han D; Goo J; Siqueira-Neto JL; Freitas-Junior LH; Song R
Eur J Med Chem; 2014 Sep; 84():395-403. PubMed ID: 25036797
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
[TBL] [Abstract][Full Text] [Related]
17. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
[TBL] [Abstract][Full Text] [Related]
18. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
[TBL] [Abstract][Full Text] [Related]
19. Optimization of benzenesulfonyl derivatives as anti-Trypanosomatidae agents: Structural design, synthesis, and pharmacological assessment against Trypanosoma cruzi and Leishmania infantum.
Freitas de Lima Hercos G; Gabriela Faleiro de Moura Lodi Cruz M; Clara Cassiano Martinho A; de Melo Resende D; Farago Nascimento D; Derksen Macruz P; Jorge Pilau E; Maria Fonseca Murta S; de Oliveira Rezende Júnior C
Bioorg Med Chem; 2024 May; 105():117736. PubMed ID: 38677111
[TBL] [Abstract][Full Text] [Related]
20. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
